Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...

Further trials comparing aspirin with newer anticoagulants (dabigatran, apixaban and rivaroxaban ... in the production of this manuscript. Atrial fibrillation (AF) is the most common cardiac ...

whether Afib patients with a low risk of stroke -- a group without an existing indication for anticoagulation -- were assigned lower-dose rivaroxaban (Xarelto) or placebo (7% vs 6.4%, HR 1.10 ...

According to company’s press statement, the approval has been granted to market a generic equivalent of Xarelto Tablets, 2.5 mg, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals, Inc.

A recent study published in JAMA has raised concerns about the safety of certain blood pressure medications for patients with ...